ADMA BIOLOGICS, INC. Restricted Cash and Cash Equivalents
ADMA BIOLOGICS, INC. (ADMA) had Restricted Cash and Cash Equivalents of $0 as of 2013-12-31, per its 10-K filed 2014-03-28.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2014-03-28
- 2013-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2013-09-30: Restricted Cash and Cash Equivalents $452.00K.
- 2013-06-30: Restricted Cash and Cash Equivalents $452.00K.
- 2013-03-31: Restricted Cash and Cash Equivalents $452.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-28 |
| 2013-09-30 | $452.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $452.00K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $452.00K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $452.00K 10-K · filed 2014-03-28 |
| 2012-09-30 | $426.96K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $426.96K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $336.96K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $336.96K 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |